Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Banyu President Quits; Merck VP To Serve As Interim Boss (Japan)

This article was originally published in PharmAsia News

Executive Summary

Banyu Pharmaceutical Co. President Haruhiko Hirate will step down on Sept. 30. David Anstice, executive vice president of the firm's U.S. parent Merck & Co., will take over as interim chief until Hirate's successor is chosen. Hirate took office in January 2004 and, due partly to a lack of new products, failed to increase earnings. Sales totaled less than 200 billion yen in fiscal 2006, well below the target of more than 300 billion yen Hirate had set when he took over as president. (Click here for more - May Require Paid Subscription



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts